Log In
Print
BCIQ
Print
Print this Print this
 

OXi4503, combretastatin A1 di-phosphate (CA1P)

Also known as: OXi-4503

  Manage Alerts
Collapse Summary General Information
Company OxiGene Inc.
DescriptionVascular disrupting agent
Molecular Target Tubulin
Mechanism of ActionMicrotubule depolymerization
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today